These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 10905482)

  • 41. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus.
    Baron AD; Kim D; Weyer C
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):63-82. PubMed ID: 12477297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetically modified rice seeds accumulating GLP-1 analogue stimulate insulin secretion from a mouse pancreatic beta-cell line.
    Sugita K; Endo-Kasahara S; Tada Y; Lijun Y; Yasuda H; Hayashi Y; Jomori T; Ebinuma H; Takaiwa F
    FEBS Lett; 2005 Feb; 579(5):1085-8. PubMed ID: 15710395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.
    Cho JM; Jang HW; Cheon H; Jeong YT; Kim DH; Lim YM; Choi SH; Yang EK; Shin CY; Son MH; Kim SH; Kim HJ; Lee MS
    Diabetes Res Clin Pract; 2011 Jan; 91(1):72-9. PubMed ID: 21093089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human embryonic stem cell differentiation into insulin secreting β-cells for diabetes.
    Bose B; Shenoy SP; Konda S; Wangikar P
    Cell Biol Int; 2012 Nov; 36(11):1013-20. PubMed ID: 22897387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
    Flamez D; Van Breusegem A; Scrocchi LA; Quartier E; Pipeleers D; Drucker DJ; Schuit F
    Diabetes; 1998 Apr; 47(4):646-52. PubMed ID: 9568699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Encapsulation of pancreatic islets within nano-thin functional polyethylene glycol coatings for enhanced insulin secretion.
    Kizilel S; Scavone A; Liu X; Nothias JM; Ostrega D; Witkowski P; Millis M
    Tissue Eng Part A; 2010 Jul; 16(7):2217-28. PubMed ID: 20163204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1).
    Wideman RD; Yu IL; Webber TD; Verchere CB; Johnson JD; Cheung AT; Kieffer TJ
    Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13468-73. PubMed ID: 16938896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Gluco-incretin hormones in insulin secretion and diabetes].
    Thorens B
    Med Sci (Paris); 2003; 19(8-9):860-3. PubMed ID: 14593618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of glucagon-like peptide-1 in the management of diabetes mellitus: cellular and molecular mechanisms.
    Lotfy M; Singh J; Rashed H; Tariq S; Zilahi E; Adeghate E
    Cell Tissue Res; 2014 Nov; 358(2):343-58. PubMed ID: 25115772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
    Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
    Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells.
    Fehmann HC; Habener JF
    Endocrinology; 1992 Jan; 130(1):159-66. PubMed ID: 1309325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus.
    Seufert J; Weir GC; Habener JF
    J Clin Invest; 1998 Jun; 101(11):2528-39. PubMed ID: 9616224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
    Lee YS; Jun HS
    Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents.
    Arakawa M; Ebato C; Mita T; Hirose T; Kawamori R; Fujitani Y; Watada H
    Biochem Biophys Res Commun; 2009 Dec; 390(3):809-14. PubMed ID: 19836346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucagon-like peptide-1 structure, function and potential use for NIDDM.
    Gefel D; Barg Y; Zimlichman R
    Isr J Med Sci; 1997 Oct; 33(10):690-5. PubMed ID: 9397146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
    Gromada J; Ding WG; Barg S; Renström E; Rorsman P
    Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
    Ma X; Guan Y; Hua X
    J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Various molecular mechanisms involved in the pathogenesis of type II diabetes and their potential therapeutic importance].
    Waeber G; Nicod P
    Schweiz Med Wochenschr; 1992 Jul; 122(30):1109-16. PubMed ID: 1496338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.
    Kawai K; Suzuki S; Ohashi S; Mukai H; Ohmori H; Murayama Y; Yamashita K
    Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.